The PTEN/TMPRSS2 assay (Metamark, Cambridge, MA, USA) is designed to predict PC aggressiveness by detecting the presence or absence of the TMPRSS2 fusion gene and PTEN deletion in biopsy samples. Here, TMPRSS2 is linked to pachyonychia congenita.